What can RJ Health help you with?
What can RJ Health help you with?
Our Resources:
White Papers
Improving Claim Submission Accuracy Starts with Provider Engagement through Greater Transparency: A Case Study on NDC Mandates
Optimization of Specialty Drug Cost Under the Medical Benefit Part 01
Optimization of Specialty Drug Cost Under the Medical Benefit Part 02
Insights into the U.S. Biosimilar Marketplace
Fraud, Waste, and Abuse Issues and Avoidance Specific to Medical Drug Claims
Medical Drug Claim Edits to Optimize Reimbursement
Addressing Drug Wastage: A $3 Billion Challenge
Webinars
Quarterly Drug Coding, Reimbursement, and Pipeline Update Webinar – Q3 2019
Precision Medicine for Health Plans
Pricing Medical Drug Claims – 18 Minute On-Demand Webinar
Where is my NDC? – 17 Minute On-Demand Webinar
Creating Pre-Payment Controls for Medically Covered Drug Costs through Automation
Introduction to Leveraging Data to Prevent and Recover Fraud, Waste and Abuse in Medical Drug Claims
Utilizing NDCs for Medical Benefit Drugs – A Payor’s Perspective
Addressing Escalating Medical Benefit Drug Pricing
Optimization of Specialty Drug Costs Under the Medical Benefit
Shedding Light on Medically Covered Specialty Drug Pricing Methods
Demystifying the HCPCS Creation Process and its Relationship with Drugs Coming to Market
Vaccine Coding Challenges – 13 Minute On-Demand Webinar
Solving for Incorrectly Mapped NDC to HCPCS/CPT® Codes and Improperly Reported NDC Units
Specialty Drug Alerts
Our current collection of specialty drug pipeline reviews available to Drug Alerts subscribers includes:
Luspatercept
PDUFA: December 4, 2019
Last Updated: October 21, 2019
DOWNLOAD NOW
Nintedinab (Ofev®)
Original FDA Approval: October 15, 2019
Last Updated: October 21, 2019
DOWNLOAD NOW
Brolucizumab-dbll (Beovu®)
Original FDA Approval: October 7, 2019
Last Updated: October 7, 2019
DOWNLOAD NOW
Afamelanotide acetate (Scenesse®)
Original FDA Approval: October 8, 2019
Last Updated: October 14, 2019
DOWNLOAD NOW
Brolucizumab
Original FDA Approval: October 7, 2019
Last Updated: October 7, 2019
DOWNLOAD NOW
Ravulizumab-cwvz (Ultomiris™)
Original FDA Approval: December 21, 2018 Last Updated: August 27, 2019
DOWNLOAD NOW
Teriparatide
Original FDA Approval: November 26, 2002
Last Updated: August 15, 2019
DOWNLOAD NOW
Riluzole
Original FDA Approval: December 21, 1995
Last Updated: July 20, 2019
DOWNLOAD NOW
Avatrombopag (Doptelet®)
Original FDA Approval: May 21, 2019
Last Updated: June 26, 2019
DOWNLOAD NOW
Tafamidis meglumine (Vyndaqel®)
Original FDA Approval: May 3, 2014
Last Updated: June 11, 2019
DOWNLOAD NOW
Ruxolitinib phosphate (Jakafi®)
Original FDA Approval: November 16, 2011
Last Updated: May 24, 2019
DOWNLOAD NOW
Ado-trastuzumab emtansine (Kadcyla®)
Original FDA Approval: February 22, 2013
Last Updated: May 9, 2019
DOWNLOAD NOW
Romosozumab-aqqg (Evenity™)
Original FDA Approval: April 9, 2019
Last Updated: April 9, 2019
DOWNLOAD NOW
Tipiracil hydrochloride + Trifluridine (Lonsurf®)
Original FDA Approval: September 22, 2015
Last Updated: February 28, 2019
DOWNLOAD NOW
Calaspoagase Pegol-mknl (Asparlas™)
Original FDA Approval: December 20, 2018
Last Updated: February 4, 2019
DOWNLOAD NOW
Cemiplimab-rwlc (Libtayo®)
Original FDA Approval: September 9, 2018
Last Updated: October 15, 2018
DOWNLOAD NOW
Patisiran (Onpattro™)
Original FDA Approval: August 10, 2018
Last Updated: August 13, 2018
DOWNLOAD NOW
Erenumab-aooe (Aimovig™)
Original FDA Approval: May 17, 2018
Last Updated: March 9, 2018
DOWNLOAD NOW
Sacituzumab Govitecan
Complete Response Letter: January 17, 2019
Last Updated: January 17, 2019
DOWNLOAD NOW